Table 1

Laboratory characteristics and clinical manifestations of patients with APS

Patient no.SexAge, yDiseaseLaboratory characteristics
Clinical manifestations, site (no. of episodes)Treatment
aCL IgGAnti-β2GPILACThrombocytopenia
43 PAPS 1199* 1358* No No Superficial vein thrombosis (1), livedo reticularis, stroke Acenocoumarol, acetylsalicylic acid 
48 PAPS 1100 945 Yes No Deep vein thrombosis, autoimmune hemolytic anemia Acenocoumarol 
43 PAPS 554 603 No Yes Deep vein thrombosis (3) Acenocoumarol, acetylsalicylic acid 
27 PAPS 770 820 No No Deep vein thrombosis (4), stroke-cerebellum infarct Acenocoumarol, acetylsalicylic acid 
29 PAPS 489 325 Yes No Peripheral arterial occlusion events (2), left lower extremity Acenocoumarol, acetylsalicylic acid 
40 APS/SLE 1008 964 No No Stroke (1), Libman-Sacks endocarditis Acenocoumarol, acetylsalicylic acid, prednisolone, hydroxychloroquine sulphate 
39 PAPS 785 973 No No Brain infarcts in MRI, spontaneous abortions (2, after 10th week of gestation) Acetylsalicylic acid 
45 APS/SLE 774 826 No Yes (<25 000) Spontaneous abortions(3, after 10th week of gestation) Acetylsalicylic acid, prednisolone 
67 PAPS 1348 1384 Yes No Spontaneous abortion (1, after 10th week of gestation), superficial/deep vein thrombosis (1/1, left lower extremity), brain microinfarcts Acenocoumarol, acetylsalicylic acid 
10 28 PAPS 345 598 Yes Yes Budd-Chiari, livedo reticularis Acetylsalicylic acid, Warfarin sodium 
Patient no.SexAge, yDiseaseLaboratory characteristics
Clinical manifestations, site (no. of episodes)Treatment
aCL IgGAnti-β2GPILACThrombocytopenia
43 PAPS 1199* 1358* No No Superficial vein thrombosis (1), livedo reticularis, stroke Acenocoumarol, acetylsalicylic acid 
48 PAPS 1100 945 Yes No Deep vein thrombosis, autoimmune hemolytic anemia Acenocoumarol 
43 PAPS 554 603 No Yes Deep vein thrombosis (3) Acenocoumarol, acetylsalicylic acid 
27 PAPS 770 820 No No Deep vein thrombosis (4), stroke-cerebellum infarct Acenocoumarol, acetylsalicylic acid 
29 PAPS 489 325 Yes No Peripheral arterial occlusion events (2), left lower extremity Acenocoumarol, acetylsalicylic acid 
40 APS/SLE 1008 964 No No Stroke (1), Libman-Sacks endocarditis Acenocoumarol, acetylsalicylic acid, prednisolone, hydroxychloroquine sulphate 
39 PAPS 785 973 No No Brain infarcts in MRI, spontaneous abortions (2, after 10th week of gestation) Acetylsalicylic acid 
45 APS/SLE 774 826 No Yes (<25 000) Spontaneous abortions(3, after 10th week of gestation) Acetylsalicylic acid, prednisolone 
67 PAPS 1348 1384 Yes No Spontaneous abortion (1, after 10th week of gestation), superficial/deep vein thrombosis (1/1, left lower extremity), brain microinfarcts Acenocoumarol, acetylsalicylic acid 
10 28 PAPS 345 598 Yes Yes Budd-Chiari, livedo reticularis Acetylsalicylic acid, Warfarin sodium 

LAC indicates lupus anticoagulant; PAPS, primary antiphospholipid syndrome; SLE, systemic lupus erythematosus; and MRI, magnetic resonance imaging.

*

Absorbance at 410 nm, cutoff (mean ± 3 SD), 52 ± 43.68.

Close Modal

or Create an Account

Close Modal
Close Modal